Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadesse M Abegaz

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us CohortWafa Ali Aldhaleei, Tadesse M Abegaz, Akshaya Srikanth Bhagavathula
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Social Determinants of Cost-Related Medication Nonadherence in the All of Us CohortTadesse M Abegaz, Emre Sezgin, Suresh K Bhavnani, et al.
Nursing Reports (Pavia, Italy)|February 26, 2026
Sociodemographic Drivers of Delays in Seeking Medical Care in the All of Us CohortTadesse M Abegaz, Efrata Ashuro Shegena, Gabriel Frietze, et al.
Frontiers in Psychiatry|March 26, 2026
Association between GLP-1 receptor agonist use and substance use disorders among individuals with type 2 diabetes or obesity: a nested case-control study in the All of Us research programTadesse M Abegaz, Muktar Ahmed, Akshaya Srikanth Bhagavathula, et al.
Clinical Drug Investigation|May 25, 2022
Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USATadesse M Abegaz, Vakaramoko Diaby, Fatimah Sherbeny, et al.
JACC. Heart Failure|April 21, 2026
Cost-Effectiveness of Tirzepatide for the Management of Heart Failure With Preserved Ejection Fraction and ObesityTadesse M Abegaz, Gabriel Frietze, Akshaya Srikanth Bhagavathula, et al.
Bioengineering (Basel, Switzerland)|February 26, 2025
Predicting Health-Related Quality of Life Using Social Determinants of Health: A Machine Learning Approach with the All of Us CohortTadesse M Abegaz, Muktar Ahmed, Askal Ayalew Ali, et al.
Pharmacy Practice|July 20, 2018
Magnitude and determinants of uncontrolled blood pressure among hypertensive patients in Ethiopia: hospital-based observational studyTadesse M Abegaz, Ousman A Abdela, Akshaya S Bhagavathula, et al.
Computers in Biology and Medicine|August 9, 2023
Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetesTadesse M Abegaz, Ahmead Baljoon, Oluwaseun Kilanko, et al.
Healthcare (Basel, Switzerland)|April 28, 2023
Application of Machine Learning Algorithms to Predict Uncontrolled Diabetes Using the All of Us Research Program DataTadesse M Abegaz, Muktar Ahmed, Fatimah Sherbeny, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us CohortWafa Ali Aldhaleei, Tadesse M Abegaz, Akshaya Srikanth Bhagavathula
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Social Determinants of Cost-Related Medication Nonadherence in the All of Us CohortTadesse M Abegaz, Emre Sezgin, Suresh K Bhavnani, et al.
Nursing Reports (Pavia, Italy)|February 26, 2026
Sociodemographic Drivers of Delays in Seeking Medical Care in the All of Us CohortTadesse M Abegaz, Efrata Ashuro Shegena, Gabriel Frietze, et al.
Frontiers in Psychiatry|March 26, 2026
Association between GLP-1 receptor agonist use and substance use disorders among individuals with type 2 diabetes or obesity: a nested case-control study in the All of Us research programTadesse M Abegaz, Muktar Ahmed, Akshaya Srikanth Bhagavathula, et al.
Clinical Drug Investigation|May 25, 2022
Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USATadesse M Abegaz, Vakaramoko Diaby, Fatimah Sherbeny, et al.
JACC. Heart Failure|April 21, 2026
Cost-Effectiveness of Tirzepatide for the Management of Heart Failure With Preserved Ejection Fraction and ObesityTadesse M Abegaz, Gabriel Frietze, Akshaya Srikanth Bhagavathula, et al.
Bioengineering (Basel, Switzerland)|February 26, 2025
Predicting Health-Related Quality of Life Using Social Determinants of Health: A Machine Learning Approach with the All of Us CohortTadesse M Abegaz, Muktar Ahmed, Askal Ayalew Ali, et al.
Pharmacy Practice|July 20, 2018
Magnitude and determinants of uncontrolled blood pressure among hypertensive patients in Ethiopia: hospital-based observational studyTadesse M Abegaz, Ousman A Abdela, Akshaya S Bhagavathula, et al.
Computers in Biology and Medicine|August 9, 2023
Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetesTadesse M Abegaz, Ahmead Baljoon, Oluwaseun Kilanko, et al.
Healthcare (Basel, Switzerland)|April 28, 2023
Application of Machine Learning Algorithms to Predict Uncontrolled Diabetes Using the All of Us Research Program DataTadesse M Abegaz, Muktar Ahmed, Fatimah Sherbeny, et al.
Pageof 2